Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer

Michelle A. Rudek, Arvind Dasari, Daniel Laheru, Ping He, Runyan Jin, Rosalind Walker, Gretchen E. Taylor, Antonio Jimeno, Ross C. Donehower, Manuel Hidalgo, Wells A. Messersmith, W. Thomas Purcell

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science